Page 24 - Read Online
P. 24

Page 8 of 9                                                      Hong et al. J Transl Genet Genom 2018;2:8. I  https://doi.org/10.20517/jtgg.2018.06

               4.   Boqh LD, Duling TA. Flow cytometry instrumentation in research and clinical laboratories. Clin Lab Sci 1993;6:167-73.
               5.   Fernandez MA, Gouveia S, Couce ML. NGS technologies as a turning point in rare disease research, diagnosis and treatment. Curr Med
                   Chem 2018;25:404-32.
               6.   Nijman IJ, van Montfrans JM, Hoogstraat M, Boes ML, van de Corput L, Renner ED, van Zon P, van Lieshout S, Elferink MG, van der
                   Burg M, Vermont CL, van der Zwaag B, Janson E, Cuppen E, Ploos van Amstel JK, van Gijn ME. Targeted next-generation sequencing: a
                   novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol 2014;133:529-34.
               7.   Kuijpers TW, Van Lier RA, Hamann D, de Boer M, Thung LY, Weening RS, Verhoeven AJ, Roos D. Leukocyte adhesion deficiency type 1
                   (LAD-I)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest 1997;100:1725-33.
               8.   Hodges KB, Vnencak-Jones CL, Larson RS, Kinney MC. Rarity of genomic instability in pathogenesis of systemic anaplastic large cell
                   lymphoma (ALCL) in immunocompetent patients. Hum Pathol 1999;30:173-7.
               9.   Jackson SE, Redeker A, Arens R, van Baarle D, van den Berg SPH, Benedict CA, Čičin-Šain L, Hill AB, Wills MR. CMV immune evasion
                   and manipulation of the immune system with aging. Geroscience 2017;39:273-91.
               10.  Dana N, Todd RF 3rd, Pitt J, Springer TA, Arnaout MA. Deficiency of a surface membrane glycoprotein (Mo1) in man. J Clin Invest
                   1984;73:153-9.
               11.  Roos D, Meischl C, de Boer M, Simsek S, Weening RS, Sanal O, Tezcan I, Güngör T, Law SK. Genetic analysis of patients with leukocyte
                   adhesion deficiency: genomic sequencing reveals otherwise undetectable mutations. Exp Hematol 2002;30:252-61.
               12.  Sligh JE Jr, Hurwitz MY, Zhu CM, Anderson DC, Beaudet AL. An initiation codon mutation in CD18 in association with the moderate
                   phenotype of leukocyte adhesion deficiency. J Biol Chem 1992;267:714-8.
               13.  van de Vijver E, Maddalena A, Sanal Ö, Holland SM, Uzel G, Madkaikar M, de Boer M, van Leeuwen K, Köker MY, Parvaneh N, Fischer
                   A, Law SK, Klein N, Tezcan FI, Unal E, Patiroglu T, Belohradsky BH, Schwartz K, Somech R, Kuijpers TW, Roos D. Hematologically
                   important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis 2012;48:53-61.
               14.  Bernard Cher TH, Chan HS, Klein GF, Jabkowski J, Schadenböck-Kranzl G, Zach O, Roca X, Law SK. A novel 3’ splice-site mutation and
                   a novel gross deletion in leukocyte adhesion deficiency (LAD)-1. Biochem Biophys Res Commun 2011;404:1099-104.
               15.  Roos D, Law SK. Hematologically important mutations: leukocyte adhesion deficiency. Blood Cells Mol Dis 2001;27:1000-4.
               16.  Fiorini M, Piovani G, Schumacher RF, Magri C, Bertini V, Mazzolari E, Notarangelo L, Notarangelo LD, Barlati S. ITGB2 mutation
                   combined with deleted ring 21 chromosome in a child with leukocyte adhesion deficiency. J Allergy Clin Immunol 2009;124:1356-8.
               17.  López Rodríguez C, Nueda A, Grospierre B, Sánchez-Madrid F, Fischer A, Springer TA, Corbí AL. Characterization of two new CD18
                   alleles causing severe leukocyte adhesion deficiency. Eur J Immunol 1993;23:2792-8.
               18.  Moore SW, Sidler D, Zaahl MG. The ITGB2 immunomodulatory gene (CD18), enterocolitis, and Hirschsprung’s disease. J Pediatr Surg
                   2008;43:1439-44.
               19.  Hinze CH, Lucky AW, Bove KE, Marsh RA, Bleesing JH, Passo MH. Leukocyte adhesion deficiency type 1 presenting with recurrent
                   pyoderma gangrenosum and flaccid scarring. Pediatr Dermatol 2010;27:500-3.
               20.  Tone Y, Wada T, Shibata F, Toma T, Hashida Y, Kasahara Y, Koizumi S, Yachie A. Somatic revertant mosaicism in a patient with leukocyte
                   adhesion deficiency type 1. Blood 2007;109:1182-4.
               21.  Allende LM, Hernández M, Corell A, García-Pérez MA, Varela P, Moreno A, Caragol I, García-Martín F, Guillén-Perales J, Olivé T,
                   Español T, Arnaiz-Villena A. A novel CD18 genomic deletion in a patient with severe leucocyte adhesion deficiency: a possible CD2/
                   lymphocyte function-associated antigen-1 functional association in humans. Immunology 2000;99:440-50.
               22.  Parvaneh N, Mamishi S, Rezaei A, Rezaei N, Tamizifar B, Parvaneh L, Sherkat R, Ghalehbaghi B, Kashef S, Chavoshzadeh Z, Isaeian A,
                   Ashrafi F, Aghamohammadi A. Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the
                   ITGB2 gene. J Clin Immunol 2010;30:756-60.
               23.  Matsuura S, Kishi F, Tsukahara M, Nunoi H, Matsuda I, Kobayashi K, Kajii T. Leukocyte adhesion deficiency: identification of novel
                   mutations in two Japanese patients with a severe form. Biochem Biophys Res Commun 1992;184:1460-7.
               24.  Uzel G, Tng E, Rosenzweig SD, Hsu AP, Shaw JM, Horwitz ME, Linton GF, Anderson SM, Kirby MR, Oliveira JB, Brown MR, Fleisher
                   TA, Law SK, Holland SM. Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood 2008;111:209-18.
               25.  Lorusso F, Kong D, Jalil AK, Sylvestre C, Tan SL, Ao A. Preimplantation genetic diagnosis of leukocyte adhesion deficiency type I. Fertil
                   Steril 2006;85:494.e15-8.
               26.  Hogg N, Stewart MP, Scarth SL, Newton R, Shaw JM, Law SK, Klein N. A novel leukocyte adhesion deficiency caused by expressed but
                   nonfunctional beta2 integrins Mac-1 and LFA-1. J Clin Invest 1999;103:97-106.
               27.  Wardlaw AJ, Hibbs ML, Stacker SA, Springer TA. Distinct mutations in two patients with leukocyte adhesion deficiency and their
                   functional correlates. J Exp Med 1990;172:335-45.
               28.  Back AL, Kwok WW, Hickstein DD. Identification of two molecular defects in a child with leukocyte adherence deficiency. J Biol Chem
                   1992;267:5482-7.
               29.  Yassaee VR, Hashemi-Gorji F, Boosaliki S, Parvaneh N. Mutation spectra of the ITGB2 gene in Iranian families with leukocyte adhesion
                   deficiency type 1. Hum Immunol 2016;77:191-5.
               30.  Arnaout MA, Dana N, Gupta SK, Tenen DG, Fathallah DM. Point mutations impairing cell surface expression of the common beta subunit
                   (CD18) in a patient with leukocyte adhesion molecule (Leu-CAM) deficiency. J Clin Invest 1990;85:977-81.
               31.  Tone Y, Wada T, Shibata F, Toma T, Hashida Y, Kasahara Y, Koizumi S, Yachie A. Somatic revertant mosaicism in a patient with leukocyte
                   adhesion deficiency type 1. Blood 2007;109:1182-4.
               32.  Ohashi Y, Yambe T, Tsuchiya S, Kikuchi H, Konno T. Familial genetic defect in a case of leukocyte adhesion deficiency. Hum Mutat
                   1993;2:458-67.
               33.  Cox DP, Weathers DR. Leukocyte adhesion deficiency type 1: an important consideration in the clinical differential diagnosis of prepubertal
                   periodontitis. A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:86-90.
               34.  Nelson C, Rabb H, Arnaout MA. Genetic cause of leukocyte adhesion molecule deficiency. Abnormal splicing and a missense mutation in a
   19   20   21   22   23   24   25   26   27   28   29